Human immunodeficiency virus and tuberculosis in Argentina: Prevalence, genotypes and risk factors

Journal of Medical Microbiology

Volumn 57, Issue 2, 2008, Pages 190-197

  Pando, Maria A ^a   De Salvo, Cristina ^b   Bautista, Christian T ^c   Eyzaguirre, Lindsay ^d   Carrion, Gladys ^e   Feola, Miguel ^f   Lado, Isabel ^g   Hoffman, Marta ^b   Biglione, Mirna M ^a,h   Carr, Jean K ^d   Montano, Silvia M ^e   Sanchez, José L ^c,i   Weissenbacher, Mercedes ^a,h   Avila, Maria M ^a,h  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Tornu Hospital   (Argentina)

^c WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^d INSTITUTE OF HUMAN VIROLOGY   (United States)

^e Peru   (Peru)

^f HOSPITAL DURAND   (Argentina)

^g Hospital Bernardino Rivadavia   (Argentina)

^h CONICET ^*  (Argentina)

ⁱ HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ISONIAZID; PROTEINASE; RIFAMPICIN; RNA DIRECTED DNA POLYMERASE; TUBERCULOSTATIC AGENT; VIRUS ENVELOPE PROTEIN;

ADULT; ARGENTINA; ARTICLE; BACTERIUM ISOLATE; DISEASE TRANSMISSION; FEMALE; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HETERODUPLEX ANALYSIS; HIGH RISK POPULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; INCIDENCE; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTIDRUG RESISTANCE; NONHUMAN; PHYLOGENY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEXUALLY TRANSMITTED DISEASE; TREPONEMA PALLIDUM; TUBERCULOSIS;

ADOLESCENT; ADULT; ARGENTINA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS B VIRUS; HIV INFECTIONS; HIV-1; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; MALE; MIDDLE AGED; PHYLOGENY; PREVALENCE; RISK FACTORS; SEQUENCE ANALYSIS, DNA; SEXUALLY TRANSMITTED DISEASES; SIPHOVIRIDAE; SUBSTANCE ABUSE, INTRAVENOUS; TREPONEMA PALLIDUM; TUBERCULOSIS;

EID: 38949137426     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.47492-0     Document Type: Article

References (23)

1. Aaron, L., Saadoun, D., Calatroni, I., Launay, O., Mémain, N., Vincent, V., Marchal, G., Dupont, B., Bouchaud, O. & other authors (2004). Tuberculosis in HIV-infected patients: a comprehensive review. Clin Microbiol Infect 10, 388-398.
2. Ȧvila, M. M., Pando, M. A., Carriȯn, G., Martinez Peralta, L., Salomȯn, H., Gȯmez Carrillo, M., Sȧnchez, J., Maulen, S., Hierholzer, J. & other authors (2002). Two epidemics in Argentina: different genetic subtypes associated with different risk groups. J Acquir Immune Defic Syndr 29, 422-426.
3. Carr, J. K., Ávila, M. M., Gómez Carrillo, M., Salomȯn, H., Hierholzer, J., Watanaveeradej, V., Pando, M. A., Negrete, M., Russell, K. L. & other authors (2001). Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America. AIDS 15, F41-F47.
4. CDC (2006). Trends in tuberculosis - United States, 2005. MMWR Morb Mortal Wkly Rep 55, 305-308.
5. Delwart, E. L., Shpaer, E. G., Louwagie, J., McCutchan, F. E., Grez, M., Rübsamen-Waigmann, H. & Mullins, J. I. (1993). Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes. Science 262, 1257-1261.
6. Dye, C. (2006). Global epidemiology of tuberculosis. Lancet 367, 938-940.
7. Espinosa, A., Vignoles, M., Carrillo, M. G., Sheppart, H., Donovan, R., Peralta, L. M., Rossi, D., Radulich, G., Salomȯn, H. & Weissenbacher, M. (2004). Intersubtype BF recombinants of HIV-1 in a population of injecting drug users in Argentina. J Acquir Immune Defic Syndr 36, 630-636.
8. Frieden, T. R., Sterling, T. R., Munsiff, S. S., Watt, C. J. & Dye, C. (2003). Tuberculosis. Lancet 362, 887-899.
9. Frothingham, R., Stout, J. E. & Hamilton, C. D. (2005). Current issues in global tuberculosis control. Int J Infect Dis 9, 297-311.
10. Liga Argentina Contra la Tuberculosis (2003). Situación de la Tuberculosis Republica Argentina, 2002. Revista Argentina del Tórax 64. Available at http://www.lalat.org.ar/revista/vol64/ actualizacion.htm.
11. Lole, K. S., Bollinger, R. C., Paranjape, R. S., Gadkari, D., Kulkarni, S. S., Novak, N. G., Ingersoll, R., Sheppard, H. W. & Ray, S. C. (1999). Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 73, 152-160.
12. Moscatello, G., Campello, P. & Benetucci, J. A. (2003). Bloodborne and sexually transmitted infections in drug users in a hospital in Buenos Aires, Argentina.Clin Infect Dis 37 (Suppl. 5), S343-347.
13. Musella, R. M., Castagnino, J. P., Weber, L., Boxaca, M. C., Weissenbacher, M. C., Abbate, E. H. & Gonzȧlez Montaner, L. J. (1990). Human immunodeficiency virus infection associated with tuberculosis. Medicina (B Aires) 50, 3-8 (in Spanish).
14. Palmero, D., Ritacco, V., Ambroggi, M., Poggi, S., Guemes Gurtabay, J., Alberti, F. & Waisman, J. (2006). Multidrug-resistant tuberculosis in AIDS patients at the beginning of the millennium. Medicina (B Aires) 66, 399-404 (in Spanish).
15. Pando, M. A., Maulen, S., Weissenbacher, M., Marone, R., Duranti, R., Peralta, L. M., Salomón, H., Russell, K., Negrete, M. & other authors (2003). High HIV-1 seroprevalence in men who have sex with men in Buenos Aires, Argentina: risk factors for infection. Int J Epidemiol 32, 735-740.
16. Pando, M. A., Biglione, M. M., Toscano, M. F., Rey, J., Russell, K. L., Negrete, M., Gianni, S., Martinez-Peralta, L., Salomȯn, H. & other authors (2004). Human immunodeficiency virus type 1 and other viral co-infections among young heterosexual men and women in Argentina. Am J Trop Med Hyg 71, 153-159.
17. Pando, M. A., Berini, C., Bibini, M., Fernández, M., Reinaga, E., Maulen, S., Marone, R., Biglione, M., Sánchez, J. & other authors (2006). Prevalence of HIV-1 and other sexually transmitted infections among female commercial sex workers in Argentina. Am J Trop Med Hyg 74, 233-238.
18. Putruele, A. M., Limongi, L. F., Legarreta, C. G., Martinez, P. R., Davidovich, A. & Kempf, N. (2006). Evaluación diagnóstica y tratamiento en 457 casos de tuberculosis. Abstracts of the 11th International Internal Medicine Congress of the Hospital de Clínicas. Medicina (B Aires) 66 (Suppl. 1), 3 (in Spanish).
19. Reid, A., Scano, F., Getahun, H., Williams, B., Dye, C., Nunn, P., De Cock, K. M., Hankins, C., Miller, B. & other authors (2006). Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration. Lancet Infect Dis 6, 483-495.
20. Weissenbacher, M., Rossi, D., Radulich, G., Sosa-Estȧni, S., Vila, M., Vivas, E., Avila, M. M., Cuchi, P., Rey, J. & Peralta, L. M. (2003). High seroprevalence of bloodborne viruses among street recruited injection drug users from Buenos Aires, Argentina. Clin Infect Dis 37 (Suppl. 5), S348-S352.
21. WHO (2002). Global Tuberculosis Control: Surveillance, Planning, Financing. Available at http://www.who.int/tb/publications/ global_report/en/. Geneva: World Health Organization.
22. WHO (2006). Tuberculosis. Fact sheet no. 104. Revised March 2007. http://www.who.int/mediacentre/factsheets/fs104/en/print.html. Last access November 2006. Geneva: World Health Organization.
23. WHO/IUATLD (2004). Project on Anti-tuberculosis Drug Resistance Surveillance. Anti-tuberculosis Drug Resistance in the World. Report no. 3. WHO/TB 99.269. Geneva: World Health Organization.